Navigation Links
deCODE genetics Announces First Quarter 2008 Financial Results
Date:5/1/2008

nd build-up of our marketing efforts for our diagnostics and deCODEme businesses.

At March 31, 2008, the company had $69.5 million in cash, cash equivalents and investments, including restricted cash equivalents, compared to $94.1 million at December 31, 2007.

"Since the beginning of the year we have sharpened our strategic focus on capturing the commercial potential of our growing portfolio of DNA-based diagnostics for assessing risk of common diseases, and of our personal genome analysis service deCODEme(TM). We have what I believe are critical competitive advantages in these areas. In the first quarter, we have built out our marketing efforts to leverage these advantages, demonstrating our leadership in the breakthrough discoveries and the expertise in genetic analysis that distinguish the deCODE brand. We have also achieved positive clinical results for our heart attack and anti-platelet compounds DG051 and DG041, results which demonstrate the potential of these compounds as we pursue partnerships for later stage clinical development. I believe our progress over the past quarter demonstrates our commitment to realizing and capturing the value coming out of our capabilities in human genetics," said Kari Stefansson, CEO of deCODE.

Recent highlights include:

Product Development

-- Diagnostics: deCODE ProCa(TM). deCODE launched its fourth DNA-based

reference laboratory test, deCODE ProCa(TM), which detects single-

letter variations in the human genome (SNPs) that the company has

associated with increased risk of prostate cancer. deCODE believes the

test will be useful for better predicting risk of prostate cancer,

helping to optimize both screening and treatment. deCODE ProCa(TM)

detects a total of six previously discovered SNPs that have been

confirmed in many populations, as well as two SNPs on chromosomes X and

2 published by deCODE in February. Becau
'/>"/>

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer
2. deCODE Lauds Federal Legislation to Ban Discrimination on the Basis of Genetic Information
3. deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results
4. U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
5. A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease
6. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
7. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
8. deCODE Genetics Announces Full-year 2007 Financial Results
9. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
10. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
11. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Dallas, Texas (PRWEB) August 23, 2014 ... on the current state of the Papain industry ... basic overview of the industry, including definitions, applications ... Chinese domestic market analysis are provided with a ... of the market. A comparison between the international ...
(Date:8/22/2014)... Today the Academy of Model Aeronautics (AMA) filed ... Appeals for the D.C. Circuit challenging the FAA’s Interpretation of ... Register on June 25, 2014. , The AMA believes ... and intent of the FAA Modernization and Reform Act of ... any new rules or regulations regarding model aircraft that are ...
(Date:8/22/2014)... , Aug. 22, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or ... periods ended June 30, 2014.  Biorem,s complete 2014 second quarter financial statements ... Financial Summary:Three-months ended June 30, , Six-months ended ... 2014 , 2013 , 2014 , ... 4,433 , 9,195 Gross profit , 56 , ...
(Date:8/22/2014)... Surrey have discovered how the receptors responsible for contractions ... The new study, published today in The FASEB ... turn regulates the cycle of all cells in the ... local biological clock and its control are weakened in ... bladder physiology and ageing. , While currently ...
Breaking Biology Technology:Papain Industry Global & China Development Trend and Proposals Analysis Research Report Available at DeepResearchReports.com 2Papain Industry Global & China Development Trend and Proposals Analysis Research Report Available at DeepResearchReports.com 3AMA Files Petition for Review of FAA’s Interpretive Rule 2Biorem Reports 2014 Second Quarter Results 2Biorem Reports 2014 Second Quarter Results 3Treatment for overactive bladder and irritable bowel syndrome advanced through pioneering research 2
... Caliper Life,Sciences, Inc. (Nasdaq: CALP ) today ... Small and Mid Cap Growth Conference in Naples, ... 4:40 p.m. EST. Kevin,Hrusovsky, President and CEO of ... business. The live webcast can be accessed at, ...
... Candidate Represents Potential New Short-Course Treatment Option for ... Serious Gram-Positive Skin Infections, Including MRSA, CAMBRIDGE, ... TARG ) announced today that it has,submitted a ... and Drug,Administration (FDA) for its lead antibiotic candidate, ...
... PROENCY will provide real-world clinical data on the ... Boston Scientific,Corporation (NYSE: BSX ) today announced ... PROENCY (PROMUS(TM), ENdeavor(R) and CYpher(R)) European,registry. The registry ... It will collect real-life clinical outcome data for ...
Cached Biology Technology:Targanta Submits Oritavancin New Drug Application 2Targanta Submits Oritavancin New Drug Application 3Targanta Submits Oritavancin New Drug Application 4Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 2Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 3Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 4
(Date:8/22/2014)... , August 22, 2014 /PRNewswire/ ... http://www.researchandmarkets.com/research/mtm27l/biometrics_market ) has announced the addition ... America 2014-2018"  report to their offering.  ... , ,Biometrics is a technology that ... based on their physical or behavioral ...
(Date:8/22/2014)... Thomson Reuters , a leading source of information ... the University of California, Riverside in its 2014 list ... our times." , To generate the list, the company ... researchers whose published work has had enormous impact. , ... 3,200 individuals who published the greatest number of highly ...
(Date:8/22/2014)... at the 29th Annual International Papillomavirus Conference shows ... Inc. combats three types of human papillomavirus, including ... cervical cancer. , When tested in several cultured ... HPV-16, HPV-18 and HPV-11 cells, according to Louise ... presented the findings at the Seattle conference. The ...
Breaking Biology News(10 mins):Biometrics Market in North America 2014-2018: Key Vendors are 3M Cogent, Cross Match, NEC and Safran SA 2Biometrics Market in North America 2014-2018: Key Vendors are 3M Cogent, Cross Match, NEC and Safran SA 35 UC Riverside scientists among world's most influential scientific minds 2
... University scientist Chittaranjan Kole was awarded the Outstanding Crop ... He was one of three scientists to receive the ... the field of crop science. He also chaired a ... this month, "Genomics and Breeding of Climate Resilient ...
... out of research conducted on the edge of the ... Gorge in Tanzania since that produced by Louis and ... special issue of the prestigious Journal of Human ... the Bernard Price Institute for Palaeontological Research, and Professor ...
... consumer products such as shampoos, gels, hair dyes and ... food crops, as reported in a paper in the ... of Sciences . Manufactured nanomaterials are man-made materials ... scale. Their effects on human health and the environment ...
Cached Biology News:Dawn of humanity illuminated in special journal edition 50 years after the Leakeys 2Soybeans susceptible to man-made materials in soil 2Soybeans susceptible to man-made materials in soil 3
... Simultaneously perform 96 assays on four ... four microarray slides with 96 (6mm x ... protein, gene expression, or screening analysis studies. ... compression fit gasket, eliminating the presence of ...
... is an automated multiplexing platform that uses ... pathogen sequence detection and pharmacogenetics applications. Multiple ... to an open and flexible electronic microarray, ... until all tests sites have been utilized. ...
... with sequence siTrio siRNA --- a ... target gene of interestis our most popular product. ... 75% knockdown of your target gene when used ... and confirmation of optimal transfection with one of ...
The Bio-Plex Manager version 3.0 to 4.0 workstation software upgrade kit is used to upgrade existing Bio-Plex Manager version 3.0 software to version 4.0 security edition software....
Biology Products: